Hollings Renton, President and CEO at ONYX PHARMACEUTICALS INC (ONXX), sold 666 shares at $31.84 ($21K) on 2007-05-17, disclosed to the SEC on 2007-05-18.
Scheduled sale ($21k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.81 | 84 | $3K | 12.6% |
| 2 | $31.84 | 582 | $19K | 87.4% |
| Total | $31.84 avg | 666 | $21K | 100% |
| Filing → |
| ANAB | SELL | 2025-06-20 | $145K | — | Filing → |
| ANAB | SELL | 2024-12-03 | $250K | — | Filing → |
| ANAB | SELL | 2024-07-17 | $613K | — | Filing → |